1-14 of 14
Authors: M Serra-Pagès
Journal Article
P1211 A faecal microbial signature, in combination with faecal calprotectin, to optimise endoscopic activity monitoring in Crohn’s Disease Free
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Page i2142, https://doi.org/10.1093/ecco-jcc/jjad212.1341
Published: 24 January 2024
Journal Article
P686 Novel grape-derived prebiotic selectively enhances abundance and metabolic activity of IBD and IBS faecal butyrate producing bacteria in an in vitro model of intestinal fermentation Free
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Pages S605–S606, https://doi.org/10.1093/ecco-jcc/jjab076.806
Published: 27 May 2021
Journal Article
P674 Definition of a microbial signature as a predictor of anti-TNFα treatment response Free
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Page S595, https://doi.org/10.1093/ecco-jcc/jjab076.794
Published: 27 May 2021
Journal Article
P678 Definition of a microbial signature as a predictor of post-surgical recurrence in patients with Crohn’s disease Free
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Pages S599–S600, https://doi.org/10.1093/ecco-jcc/jjab076.798
Published: 27 May 2021
Journal Article
P687 Development of a panel of microbial markers to distinguish transient from pathological dysbiosis Free
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Page S606, https://doi.org/10.1093/ecco-jcc/jjab076.807
Published: 27 May 2021
Journal Article
P848 A novel grape-derived prebiotic selectively enhances abundance and metabolic activity of butyrate producing bacteria in faecal samples of inflammatory bowel disease Free
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Pages S653–S654, https://doi.org/10.1093/ecco-jcc/jjz203.976
Published: 15 January 2020
Journal Article
P846 Comparative study of faecal microbiota in Crohn’s disease patients in remission with and without surgical resection Free
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Page S653, https://doi.org/10.1093/ecco-jcc/jjz203.974
Published: 15 January 2020
Journal Article
P835 Correlation between microbial markers and faecal calprotectin in IBD patients Free
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Page S648, https://doi.org/10.1093/ecco-jcc/jjz203.963
Published: 15 January 2020
Journal Article
P162 RAID-Monitor: a new non-invasive method to determine endoscopic activity in inflammatory bowel diseases Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S169–S170, https://doi.org/10.1093/ecco-jcc/jjy222.286
Published: 25 January 2019
Journal Article
P251 RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S222, https://doi.org/10.1093/ecco-jcc/jjy222.375
Published: 25 January 2019
Journal Article
P213 RAID-IBS Diagnosis: A new non-invasive method to support Irritable Bowel Syndrome diagnosis Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Page S207, https://doi.org/10.1093/ecco-jcc/jjx180.340
Published: 16 January 2018
Journal Article
P143 From biopsies to fecal samples: challenging Faecalibacterium prausnitzii and related phylogroups as potential biomarkers for IBD Get access
Journal of Crohn's and Colitis, Volume 11, Issue suppl_1, February 2017, Pages S148–S149, https://doi.org/10.1093/ecco-jcc/jjx002.269
Published: 26 January 2017
Journal Article
P201 A faecal bacterial markers correlates with Calprotectin for IBD activity monitoring? Get access
Journal of Crohn's and Colitis, Volume 11, Issue suppl_1, February 2017, Page S178, https://doi.org/10.1093/ecco-jcc/jjx002.326
Published: 26 January 2017
Journal Article
P455 Improvement of ulcerative-colitis-associated microbiota dysbiosis after treatment with mesalazine-MMX (Mezavant®) using mucosal Faecalobacterium prausnitzii/Escherichia coli index as a marker Get access
Journal of Crohn's and Colitis, Volume 8, Issue Supplement_1, February 2014, Pages S255–S256, https://doi.org/10.1016/S1873-9946(14)60575-4
Published: 01 February 2014
